Sairah Ahmed, MD
Associate Professor
Department of Lymphoma/Myeloma
Director of CART Program
The University of Texas MD Anderson Cancer Center
Houston, Texas

Ann S. LaCasce, MD, MMSc
Associate Professor of Medicine
Harvard Medical School
Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology
Boston, Massachusetts

John P. Winters III, MD
Hematology/Oncology Physician
New England Cancer Specialists
Scarborough, Maine

Target Audience

The educational design of this activity addresses the needs of hematologists/oncologists related to the treatment of B-cell non-Hodgkin lymphoma (NHL).

Program Overview

Community hematologist/oncologists (hem-oncs) are tasked with staying up to date on the latest clinical trial data across multiple oncologic disease states, which typically entails proficiency with rapidly changing management guidelines. During two of the largest global hem-onc conferences, American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) Hybrid Congress, data were presented that highlight new findings and treatment updates in patients with non-Hodgkin lymphoma (NHL).  Our expert hem-onc faculty, Drs. Sairah Ahmed and Ann LaCasce, distill the pivotal clinical trial data across diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and other subtypes of NHL (eg, marginal zone lymphoma) and answer practice-based questions from their community hem-onc colleagues.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe the newer US Food and Drug Administration–approved therapies in various non-Hodgkin lymphoma subtypes
  • Summarize the most recent clinical trial data on investigational therapies in non-Hodgkin lymphoma, emerging from recent hematology/oncology conferences
  • Discuss approaches to implementation of new findings and therapeutic options in non-Hodgkin lymphoma therapies
Webcast Series 
0.50 AMA PRA

What’s New In Diffuse Large B-Cell Lymphoma

Webcast Series 
0.50 AMA PRA

What’s New In Follicular Lymphoma

Webcast Series 
0.50 AMA PRA

What’s New In Mantle Cell Lymphoma

Webcast Series 
0.50 AMA PRA

What’s New In Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Webcast Series 
0.50 AMA PRA

Hot Topics In Non-Hodgkin Lymphoma

available resources
linked resources
Suggested Reading
Clinical Conference Highlights™

Shining a Light on Non-Hodgkin Lymphoma

Highlights From Recent National and International Conferences